NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments.
Neogenomics stock last closed at $14.86, up 1.36% from the previous day, and has decreased 6.25% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 0.16 percentage points. Neogenomics stock is currently +22.56% from its 52-week low of $12.13, and -22.26% from its 52-week high of $19.12.
As of Jan 24, 2025, there are 128.36M NEO shares outstanding. The market value of NEO is $1.91B. In the last 24 hours, 429,153 NEO shares were traded.
How to Buy Neogenomics Stock
Wondering how to invest in Neogenomics stock? Here's how.
Choose where to buy Neogenomics stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Neogenomics stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Pick your payment method and add your info.
Analyze Neogenomics stock: The Neogenomics ticker symbol is NEO. Is Neogenomics stock a good investment? Should you buy shares of NEO? How do NEO's underlying business fundamentals look? Do top analysts think Neogenomics is a good buy? Why has NEO's stock price moved recently? (Hint: Our stock market research website can help you understand if NEO is a good stock to buy).
Make your NEO trade: Decide if you will purchase NEO shares at the current market price or use a limit order to buy NEO shares at a given price.
Keep an eye on your NEO investment: Create a watchlist to monitor your investment in Neogenomics shares.
Step 1: Choose where to buy Neogenomics stock
You will need a brokerage account in order to access the NASDAQ market and buy NEO shares.
A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to world financial markets: From Tech to Financial Services, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you can invest in NEO stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Neogenomics stock
After you have figured out the best place to buy Neogenomics stock, it's crucial to research their stock prior to investing, so you truly wrap your head around the risk as well as the opportunity.
Neogenomics Numbers
NEO Price
$14.86
1w %
4.57%
1y %
-6.25%
5y %
-53.99%
P/E
-24.36x
P/B
2.1x
P/S
2.93x
PEG
N/A
Revenue
$644.12M
Earnings
-$77.73M
Fore. Rev. Growth
14.65%
Fore. Earn. Growth
N/A
Market Cap
$1.91B
Next Earnings
Feb 18, 2025
Next Dividend
N/A
Neogenomics Due Diligence Checks
WallStreetZen was created to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on NEO's stock page.
Is NEO stock undervalued or overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge NEO's true value.
Using relative valuations metrics:
NEO could be undervalued based on its P/B ratio of 2.1x, relative to Diagnostics & Research industry P/B ratio of 4.23x
You can access additional valuation analysis on NEO's stock here.
NEO Financial Health Overview
Positive Health Checks:
NEO has cash burn of 21512000. It has sufficient cash and short-term investments to cover this for at least one year.
There are more short-term assets than long-term liabilities on the NEO balance sheet.
NEO profit margin has gone up from -16.8% to -12.1% in the past year.
NEO has $387.81M in cash and short term investments. This is sufficient to cover its annual cash burn of $21.51M.
There are more short-term assets than short-term liabilities on the NEO balance sheet.
Negative Health Checks:
Total NEO debt is higher than 5 years ago, relative to shareholder equity.
NEO has a relatively high debt to equity ratio of 0.81.
Is Neogenomics stock a Buy, Hold, or Sell, according to analysts?
Out of 5 Wall Street analysts who give recommendations on NEO, the consensus analyst rating on Neogenomics is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Last year, NEO revenue was $644.12M. Over the past 5 year, NEO's revenue has gone up by 11.22% per year. This was faster than the Diagnostics & Research industry average of 9.64%.
No, Neogenomics doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Make your NEO trade
There are two primary options:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are generally the easiest way to buy.
Limit order: A limit order is an order to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a particular dollar amount limit, place a limit order.
Hit the Open button and eToro will place the order.
If you need additional info about investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Neogenomics share?
As of Jan 24, 2025, it costs $14.86 to buy one share of Neogenomics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $7, you can buy 0.471 shares of NEO.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.